TrustCore Financial Services’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AWA
TrustCore Financial Services's BMY Position: Q4 2022 in Review
TrustCore Financial Services increased its Bristol-Myers Squibb (BMY) stake by 0.21% in Q4 2022, buying an estimated $3.77K and bringing the position to 24,305 shares worth $1.75M. The position accounts for 0.15% of the portfolio, ranked #79.
TrustCore Financial Services first reported a position in BMY in Q4 2017 and has held it in 20 quarters since. The position peaked at $1.87M in Q2 2022. 2,601 funds tracked by Wall St. Rank hold BMY as of Q4 2022.
- TrustCore Financial Services held 24,305 shares of Bristol-Myers Squibb worth $1.75M as of Q4 2022.
- TrustCore Financial Services bought 50 Bristol-Myers Squibb shares in Q4 2022, an estimated $3.77K.
- Bristol-Myers Squibb made up 0.15% of TrustCore Financial Services's portfolio in Q4 2022, its #79 holding.
- TrustCore Financial Services first reported a position in Bristol-Myers Squibb in Q4 2017 and has held it in 20 quarters since.
- TrustCore Financial Services's Bristol-Myers Squibb position peaked at $1.87M in Q2 2022.
- 2,601 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2022.
Based on TrustCore Financial Services's 13F filing for Q4 2022, filed 13 Feb 2023.